Clinical Trial Update: Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome. [Phase 1]

View source ↗

Summary

Phase 1 study of KM-023 in healthy volunteers and patients with Olmsted syndrome; trial status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olmsted Syndrome

Drugs mentioned

• KM-023

Snippet

Sponsor: Kamari Pharma Ltd | Conditions: Olmsted Syndrome | Phase 1 | Status: RECRUITING